The prevalence of LS is currently not well characterized (Brems et al., 2012), but variants in SPRED1 are commonly identified in patients with a clinical diagnosis of NF1 who do not have detectable alterations in NF1 (Messiaen et al., 2009). This evidence concerns the gene SPRED1 and Leigh syndrome.